← FDA Drug Approvals (Drugs@FDA)
OXTRIPHYLLINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS
Drug application
- FDA Application #
ANDA087866- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXTRIPHYLLINE
- Generic name
- Oxtriphylline
- Active ingredients
- OXTRIPHYLLINE
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- WATSON LABS
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown